First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery

被引:62
作者
Menichincheri, Maria [1 ]
Bargiotti, Alberto [1 ]
Berthelsen, Jens [1 ]
Bertrand, Jay A. [1 ]
Bossi, Roberto [1 ]
Ciavolella, Antonella [1 ]
Cirla, Alessandra [1 ]
Cristiani, Cinzia [1 ]
Croci, Valter [1 ]
D'Alessio, Roberto [1 ]
Fasolini, Marina [1 ]
Fiorentini, Francesco [1 ]
Forte, Barbara [1 ]
Isacchi, Antonella [1 ]
Martina, Katia [2 ]
Molinari, Antonio [2 ]
Montagnoli, Alessia [1 ]
Orsini, Paolo [1 ]
Orzi, Fabrizio [1 ]
Pesenti, Enrico [1 ]
Pezzetta, Daniele [1 ]
Pillan, Antonio [1 ]
Poggesi, Italo [3 ]
Roletto, Fulvia [1 ]
Scolaro, Alessandra [1 ]
Tato, Marco [1 ]
Tibolla, Marcellino [1 ]
Valsasina, Barbara [1 ]
Varasi, Mario [4 ]
Volpi, Daniele [1 ]
Santocanale, Corrado [1 ,5 ]
Vanotti, Ermes [1 ]
机构
[1] Nerviano Med Sci Srl, I-20014 Milan, Italy
[2] Univ Turin, Dipartimento Chim IFM, Turin, Italy
[3] GlaxoSmithKline SpA, Verona, Italy
[4] Genextra Grp SpA, Milan, Italy
[5] Natl Univ Ireland, Natl Ctr Biomed Engn & Sci, Galway, Ireland
关键词
HUMAN CDC7-RELATED KINASE; IN-VITRO PHOSPHORYLATION; DNA-REPLICATION; HUMAN HOMOLOG; PROTEIN; CELLS; IDENTIFICATION; INITIATION; COMPLEX; GROWTH;
D O I
10.1021/jm800977q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cdc7 kinase is a key regulator of the S-phase of the cell cycle, known to promote the activation of DNA replication origins in eukaryotic organisms. Cdc7 inhibition can cause tumor-cell death in a p53-independent manner, supporting the rationale for developing Cdc7 inhibitors for the treatment of cancer. In this paper, we conclude the structure-activity relationships study of the 2-heteroaryl-pyrrolopyridinone class of compounds that display potent inhibitory activity against Cdc7 kinase. Furthermore, we also describe the discovery of 89S, [(S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoro-ethyl)-1,5,6,7-tetrahydropyrrolol[3,2-c]pyridin-4-one], as a potent ATP mimetic inhibitor of Cdc7. Compound 89S has a K-i value of 0.5 nM, inhibits cell proliferation of different tumor cell lines with an IC50 in the submicromolar range, and exhibits in vivo tumor growth inhibition of 68% in the A2780 xenograft model.
引用
收藏
页码:293 / 307
页数:15
相关论文
共 37 条
[1]   Pyrrolopyridine inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2) [J].
Anderson, David R. ;
Meyers, Marvin J. ;
Vernier, William F. ;
Mahoney, Matthew W. ;
Kurumbail, Ravi G. ;
Caspers, Nicole ;
Poda, Gennadiy I. ;
Schindler, John F. ;
Reitz, David B. ;
Mourey, Robert J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (11) :2647-2654
[2]  
Avdeef Alex, 2005, Expert Opin Drug Metab Toxicol, V1, P325, DOI 10.1517/17425255.1.2.325
[3]   DNA replication in eukaryotic cells [J].
Bell, SP ;
Dutta, A .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :333-374
[4]   Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine) [J].
Bergman, AM ;
Pinedo, HM ;
Peters, GJ .
DRUG RESISTANCE UPDATES, 2002, 5 (01) :19-33
[5]   Structural characterization of the GSK-3β active site using selective and non-selective ATP-mimetic inhibitors [J].
Bertrand, JA ;
Thieffine, S ;
Vulpetti, A ;
Cristiani, C ;
Valsasina, B ;
Knapp, S ;
Kalisz, HM ;
Flocco, M .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 333 (02) :393-407
[6]   The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective [J].
Bjornsson, TD ;
Callaghan, JT ;
Einolf, HJ ;
Fischer, V ;
Gan, L ;
Grimm, S ;
Kao, J ;
King, SP ;
Miwa, G ;
Ni, L ;
Kumar, G ;
McLeod, J ;
Obach, SR ;
Roberts, S ;
Roe, A ;
Shah, A ;
Snikeris, F ;
Sullivan, JT ;
Tweedie, D ;
Vega, JM ;
Walsh, J ;
Wrighton, SA .
JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (05) :443-469
[7]  
Chabner B.A., 2001, The Pharmacological Basis of Therapeutics, P1389
[8]   A fully automated method for accurate mass determination using high-performance liquid chromatography with a quadrupole/orthogonal acceleration time-of-flight mass spectrometer [J].
Colombo, M ;
Sirtori, FR ;
Rizzo, V .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2004, 18 (04) :511-517
[9]   Regulation of early events in chromosome replication [J].
Diffley, JFX .
CURRENT BIOLOGY, 2004, 14 (18) :R778-R786
[10]   A human homolog of the yeast CDC7 gene is overexpressed in some tumors and transformed cell lines [J].
Hess, GF ;
Drong, RF ;
Weiland, KL ;
Slightom, JL ;
Sclafani, RA ;
Hollingsworth, RE .
GENE, 1998, 211 (01) :133-140